On Invalid Date, Durect (NASDAQ: DRRX) reported Q4 2023 earnings per share (EPS) of -$0.01, up 97.83% year over year. Total Durect earnings for the quarter were -$1.44 million. In the same quarter last year, Durect's earnings per share (EPS) was -$0.46.
As of Q2 2024, Durect's earnings has grown year over year. Durect's earnings in the past year totalled -$27.62 million.
What is DRRX's earnings date?
Durect's earnings date is Invalid Date. Add DRRX to your watchlist to be reminded of DRRX's next earnings announcement.
What was DRRX's revenue last quarter?
On Invalid Date, Durect (NASDAQ: DRRX) reported Q4 2023 revenue of $2.67 million up 19.49% year over year. In the same quarter last year, Durect's revenue was $3.32 million.
What was DRRX's revenue growth in the past year?
As of Q2 2024, Durect's revenue has grown -55.67% year over year. This is 65.78 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.11%. Durect's revenue in the past year totalled $8.55 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.